These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 36855254)

  • 1. Fabrication of solid lipid nanoparticles-based patches of paroxetine and their
    Pervaiz F; Saba A; Yasin H; Buabeid M; Noreen S; Khan AK; Murtaza G
    Artif Cells Nanomed Biotechnol; 2023 Dec; 51(1):108-119. PubMed ID: 36855254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability.
    El-Nabarawi MA; Bendas ER; El Rehem RT; Abary MY
    Int J Pharm; 2013 Feb; 443(1-2):307-17. PubMed ID: 23337629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
    Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
    J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide-Solid Lipid Nanoparticles in Chitosan Patches for Transdermal Application: Box-Behnken Design, Characterization, and In Vivo Evaluation.
    Ali HSM; Namazi N; Elbadawy HM; El-Sayed AAA; Ahmed SA; Bafail R; Almikhlafi MA; Alahmadi YM
    Int J Nanomedicine; 2024; 19():209-230. PubMed ID: 38223883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Both in vitro and in vivo Kinetics by SLNs Induced Transdermal System of Furosemide: A Novel Approach.
    Mannam R; Yallamalli IM
    Recent Pat Drug Deliv Formul; 2017; 11(3):187-197. PubMed ID: 29189185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization, Formulation, and Ex vivo Evaluation of Solid Lipid Nanoparticles for Transdermal Delivery of Diltiazem Hydrochloride.
    Jaiswal S; Gupta GD
    Pharm Nanotechnol; 2024 Oct; ():. PubMed ID: 39400025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery.
    Ramzan M; Gourion-Arsiquaud S; Hussain A; Gulati JS; Zhang Q; Trehan S; Puri V; Michniak-Kohn B; Kaur IP
    Drug Deliv Transl Res; 2022 Jul; 12(7):1659-1683. PubMed ID: 34993923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of Statistical Tooling Techniques for Designing of Carvedilol Nanolipid Transferosomes and its Dermatopharmacokinetic and Pharmacodynamic Studies.
    Selvaraj BR; Sridhar SK; Kesavan BR; Palagati S
    Pharm Nanotechnol; 2020; 8(6):452-470. PubMed ID: 32988361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient approach for development and optimisation of curcumin-loaded solid lipid nanoparticles' patch for transdermal delivery.
    Sabir F; Qindeel M; Rehman AU; Ahmad NM; Khan GM; Csoka I; Ahmed N
    J Microencapsul; 2021 Jun; 38(4):233-248. PubMed ID: 33689550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization.
    Dudhipala N; Ettireddy S; Youssef AAA; Puchchakayala G
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
    Dudhipala N; Veerabrahma K
    Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

  • 13. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition.
    Shah P; Chavda K; Vyas B; Patel S
    Drug Deliv Transl Res; 2021 Jun; 11(3):1166-1185. PubMed ID: 32804301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid-based nanoparticulate system for sustained release and enhanced in-vitro cytotoxic effect of 5-fluorouracil on skin Melanoma and squamous cell carcinoma.
    Ali A; Madni A; Shah H; Jamshaid T; Jan N; Khan S; Khan MM; Mahmood MA
    PLoS One; 2023; 18(2):e0281004. PubMed ID: 36854019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal Delivery of Curcumin-Loaded Solid Lipid Nanoparticles as Microneedle Patch: an In Vitro and In Vivo Study.
    Prabhu A; Jose J; Kumar L; Salwa S; Vijay Kumar M; Nabavi SM
    AAPS PharmSciTech; 2022 Jan; 23(1):49. PubMed ID: 34988698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of piroxicam from solid lipid nanoparticle as an effective anti-inflammatory therapeutics in vivo.
    Peng LH; Wei W; Shan YH; Chong YS; Yu L; Gao JQ
    Drug Dev Ind Pharm; 2017 Jan; 43(1):55-66. PubMed ID: 27498809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
    Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
    Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Domperidone Solid Lipid Nanoparticles: In Vitro and In Vivo Characterization.
    Shazly GA; Alshehri S; Ibrahim MA; Tawfeek HM; Razik JA; Hassan YA; Shakeel F
    AAPS PharmSciTech; 2018 May; 19(4):1712-1719. PubMed ID: 29532427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.